Related Experiment Video
Updated: May 19, 2026

15:23
Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
Published on: May 13, 2010
Naturally occurring autoantibodies against β-Amyloid
Jan-Philipp Bach1, Richard Dodel
1Department of Neurology, Philipps-University Marburg, Germany.
Advances in Experimental Medicine and Biology
|August 21, 2012
Summary
Naturally occurring antibodies (NAbs) against amyloid-beta (Aβ) show potential in treating neurodegenerative disorders. Research suggests these NAbs may inhibit Aβ toxicity and improve cognition, with a Phase-III trial underway for Alzheimer's disease (AD).
Area of Science:
- Immunology
- Neuroscience
- Biochemistry
Background:
- Naturally occurring antibodies (NAbs) have been studied for over 30 years.
- Recent findings show NAbs targeting proteins in neurodegenerative disorders, including amyloid-beta (Aβ).
Purpose of the Study:
- To summarize current knowledge on NAbs against Aβ.
- To discuss the hypothesized functions of anti-Aβ NAbs in neurodegeneration.
Main Methods:
- Literature review of studies on NAbs against Aβ.
- Analysis of evidence for NAb functions in inhibiting Aβ fibrillation and toxicity.
- Examination of cognitive effects in animal models.
Main Results:
- Anti-Aβ NAbs are hypothesized to inhibit Aβ fibrillation and toxicity.
- These NAbs may interfere with Aβ oligomers and improve cognition in mouse models.
- A Phase-III study using IVIG is initiated for Alzheimer's disease (AD) patients.
Conclusions:
- NAbs against Aβ represent a promising area for neurodegenerative disease research.
- Clinical trials will determine if NAbs can alter the course of diseases like AD.
- Further understanding of NAb functions is crucial for therapeutic development.
Related Concept Videos
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

